Jenny Bain
Papers
1
Total Citations
310
H-Index
1
About
Jenny Bain’s research has centered on the molecular mechanisms of stress-activated protein kinases, particularly the p38 MAPK family, and their roles in inflammatory disease. Her most influential work, the 2005 study “BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo,” has garnered over 310 citations and fundamentally reshaped understanding of kinase inhibitor specificity. Bain demonstrated that the clinical compound BIRB796—then thought to target only p38α and p38β—also inhibits p38γ (SAPK3) at higher concentrations, revealing a broader inhibitory profile with critical implications for drug development. This finding provided a more complete picture of BIRB796’s mechanism in ongoing clinical trials for inflammatory conditions, and it underscored the importance of thorough isoform profiling in kinase-targeted therapies. Bain’s work has been instrumental in guiding both basic kinase biology and translational pharmacology, helping researchers design more selective inhibitors and interpret preclinical data with greater accuracy. Her contributions remain a cornerstone for those studying p38 signaling, drug specificity, and the therapeutic targeting of stress-activated pathways.
Research Focus
Key Achievements
Top Papers
- 1BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo310 citations · 2005